Several of the section officers and I are organizing a webinar(s) about data privacy. More-> more details will be forthcoming.
In some searches for background information about privacy, this interesting opinion arising from the European authorities about
Anonymisation
My work is mainly in pharma and this appears applicable to anononymizing that occurs in blinded clinical trials
Excerpting main techniques for anonymisation
...The main anonymisation techniques, namely randomization and generalization, are described
in this opinion. In particular, the opinion discusses noise addition, permutation, differential
privacy, aggregation, k-anonymity, l-diversity and t-closeness. It explains their principles,
their strengths and weaknesses, as well as the common mistakes and failures related to the use
of each technique
https://ec.europa.eu/justice/article-29/documentation/opinion-recommendation/files/2014/wp216_en.pdf
this refers to "recital 26" in GDPR
here
https://gdpr-info.eu/recitals/no-26/
https://www.privacy-regulation.eu/en/recital-26-GDPR.htm
------------------------------
Chris Barker, Ph.D.
2023 Chair Statistical Consulting Section
Consultant and
Adjunct Associate Professor of Biostatistics
www.barkerstats.com---
"In composition you have all the time you want to decide what to say in 15 seconds, in improvisation you have 15 seconds."
-Steve Lacy
------------------------------